Oncolytics Biotech/ CA6823101077 /
| 2024-09-25 5:23:30 PM | Chg. -0.01 | Volume | Bid9:54:42 PM | Ask9:56:44 PM | High | Low |
|---|---|---|---|---|---|---|
| 0.90USD | -1.10% | 500 Turnover: 449.92 |
0.89Bid Size: 15 | 0.90Ask Size: 4 | 0.90 | 0.90 |
GlobeNewswire
06-20
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Gr...
GlobeNewswire
06-20
Biotechs Race to Develop New Treatments as Global Pancreatic Cancer Market Size Expected to Reach $7...
GlobeNewswire
05-24
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7...
Newsfile Corp
03-06
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market - A Race Worth Winning
GlobeNewswire
03-05
Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Trea...
Newsfile Corp
02-15
Cancer Immunotherapy Stocks - Tapping into Immune Systems for Next Generation Treatments
GlobeNewswire
02-14
Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focu...
GlobeNewswire
01-09
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
GlobeNewswire
2018-12-12
Oncolytics Biotech® Announces First Patient Treated in Study Combining Pelareorep, Carfilzomib and t...
GlobeNewswire
2018-12-03
Oncolytics Biotech® Announces Increased PD-L1 Expression When Combining Pelareorep with a Proteasom...
GlobeNewswire
2018-11-29
Oncolytics Biotech® Announces Appointment of Rita Laeufle, M.D., as Chief Medical Officer
GlobeNewswire
2018-11-26
Oncolytics Biotech® Announces First Patient Treated in Phase 2 Study Combining Pelareorep and Keytru...
GlobeNewswire
2018-11-12
Oncolytics Biotech® Reports 2018 Third Quarter Financial Results and Provides Corporate Update
GlobeNewswire
2018-11-09
Oncolytics Biotech® Announces Presentation at the Society for Immunotherapy of Cancer 2018 Annual Me...
GlobeNewswire
2018-11-05
Oncolytics Biotech® to Host Conference Call to Discuss Third Quarter Financial Results and Corporat...
GlobeNewswire
2018-11-01
Oncolytics Biotech® Announces Abstract for ASH Annual Meeting & Exposition Demonstrating Pelareorep ...
GlobeNewswire
2018-10-22
Oncolytics Biotech® Announces Positive Clinical Trial Results for Pelareorep in Patients with KRAS M...
GlobeNewswire
2018-10-11
Oncolytics Biotech® Announces Publication of Positive Clinical Results for Pelareorep in Abstract f...
GlobeNewswire
2018-10-02
Oncolytics Biotech® Announces a Publication Demonstrating That Intravenously Delivered Oncolytic Vir...
GlobeNewswire
2018-09-28
Oncolytics Biotech® Enters into Common Stock Purchase Agreement for up to US$26 Million with Lincoln...
GlobeNewswire
2018-09-26
Oncolytics Biotech® to Present at the Ladenburg Thalmann 2018 Healthcare Conference
